Write For Us

Will Make Profit On Vaccine When We Enter Private Market: Adar Poonawalla To NDTV

Sponsored Post Vitamin D2 Canada Persia
111 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Serum Institute of India CEO Adar Poonawalla told NDTV in an exclusive chat that he will make a profit on the Covishield vaccine after they enter the private market. He also said that Rs 200, the special price the government has bought the vaccine for, is "substantially low" and the cost of manufacture is upwards of Rs 300. He also said that he hopes manufacturers will lower the prices for countries like India.

NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
Category
Asia
Tags
NDTV 24x7, Covid Vaccine, Coronavirus
Sign in or sign up to post comments.
Be the first to comment